{
    "nct_id": "NCT01894620",
    "title": "Investigating the Effect of Repetitive Transcranial Magnetic Stimulation as a Treatment for Alzheimer's Disease and on Sleep Quality",
    "status": "COMPLETED",
    "last_update_time": "2021-02-22",
    "description_brief": "This research is being conducted to study whether rTMS (repetitive Transcranial Magnetic Stimulation) could be potentially used as a treatment for Alzheimer's disease. rTMS is a technique that stimulates the brain by rapidly switching a magnetic field in a coil placed over your head. Prior to rTMS, single pulse TMS will be used to localize the specific brain region that we are interested in.",
    "description_detailed": "Upon meeting the inclusion criteria and providing informed consent, each participant will complete a series of cognitive assessments and rTMS treatments at the TMS Lab at Riverview Health Center. Each treatment session will involve implementing rTMS, while the patient is involved in a cognitive exercise such as naming object or action. The study sessions will be scheduled as follows: Block 1: 5 days/week for two weeks followed by 2 days a week for 1 week, followed by once a week for 1 week (total of 13 treatments); Pause: 4 weeks of no treatment; and Block 2: another 13 sessions of treatment with the same pattern as Block 1. One of these two sets of treatment (Block 1 or Block 2) will be sham and one will be real. Sham treatment sessions are identical to real treatment sessions, except that there is no magnetic stimulation. Patients will be randomly assigned to receive either sham or real treatment first. The purpose of sham treatment is to have a control group data that the plausible improvement as a result of rTMS can be compared to. By designing two sets of sham-real or real-sham treatment sessions, every participant will receive a real treatment, while we will also have control data.\n\nThe cognitive assessments will be done at the baseline, and then on weekly basis. A subgroup of the study population will be recruited for investigating the second objective: effect of rTMS on sleep quality. Those patients will be required to sign a second consent; then, the patients will go through full-night sleep study at Misericordia Health Center at the same time intervals as their cognitive assessments.",
    "phase": [
        "NA"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "rTMS Real-sham",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                },
                {
                    "id": "FG001",
                    "title": "rTMS Sham-real",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "rTMS Real-sham",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                },
                {
                    "id": "BG001",
                    "title": "rTMS Sham-real",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "6"
                        },
                        {
                            "groupId": "BG001",
                            "value": "5"
                        },
                        {
                            "groupId": "BG002",
                            "value": "11"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "68.83",
                                            "spread": "10.48"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "68.25",
                                            "spread": "9.88"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "68.60",
                                            "spread": "9.67"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Canada",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Cognitive Improvement Measured Using Montreal Cognitive Assessment (MoCA)",
                    "description": "We anticipate to see a cognitive improvement as measured by the Montreal Cognitive Assessment (MoCA) after two weeks of applying rTMS. This assessment tool gives a score from 0 to 30 points, with higher scores representing better cognitive ability.",
                    "populationDescription": "Results are divided into the two treatment type groups (real vs. sham).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "MOCA score change at 2 weeks",
                    "timeFrame": "Change between baseline and 2 weeks after the start of treatment",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "rTMS With Sham Coil",
                            "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                        },
                        {
                            "id": "OG001",
                            "title": "rTMS With Real Coil",
                            "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.667",
                                            "spread": "1.116"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.8",
                                            "spread": "0.633"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Improvement in Sleep Quality",
                    "description": "We anticipate to see an improvement on the sleep quality of the patients (assessed by EEG waves during sleep) after 4 weeks of rTMS treatment.",
                    "populationDescription": "Note that this aspect of the study was not performed. Therefore, no data is available.",
                    "reportingStatus": "POSTED",
                    "timeFrame": "After four weeks after the start of treatment",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "rTMS Real-sham",
                            "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                        },
                        {
                            "id": "OG001",
                            "title": "rTMS Sham-real",
                            "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "0"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Full study (18 months)",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "rTMS With Sham Coil",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 10,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 10
                },
                {
                    "id": "EG001",
                    "title": "rTMS With Real Coil",
                    "description": "rTMS real-sham and rTMS sham-real interventions. Each patient will receive both real and sham treatment in two different blocks of time. The assessments after the sham treatment will serve as placebo effect compared to those after real treatment.\n\nrTMS real-sham: In this intervention patients receive 4 weeks of rTMS treatment with real coil and then 4 weeks of treatment with sham coil; there will be 4 weeks of break between the two blocks of treatment.\n\nrTMS sham-real: In this intervention patients receive 4 weeks of rTMS treatment with sham coil and then 4 weeks of treatment with real coil; there will be 4 weeks of break between the two blocks of treatment.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 10,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 10
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Dr Zahra Moussavi",
                "organization": "University of Manitoba",
                "email": "Zahra.Moussavi@umanitoba.ca",
                "phone": "204 474-7023"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [],
    "placebo": [],
    "explanation_target": [
        "Reason: The intervention is repetitive transcranial magnetic stimulation (rTMS), a non\u2011invasive neuromodulation device technique that stimulates cortical brain regions. The trial aim is to treat Alzheimer\u2019s disease and improve sleep quality, with the primary therapeutic intent appearing to be symptomatic/cognitive improvement rather than targeting molecular pathology (e.g., amyloid or tau). rTMS is therefore best classified by intended clinical effect (cognitive enhancement) rather than as a biologic or small molecule. \ue200cite\ue202turn0search0\ue202turn0search2\ue201",
        "Act: Key extracted details \u2014 Intervention: rTMS (repetitive Transcranial Magnetic Stimulation); Procedure: single\u2011pulse TMS to localize target followed by rTMS; No drug is involved and no drug/placebo is listed in the description. Multiple meta\u2011analyses and RCT reviews report that rTMS can improve global cognition or specific cognitive measures in mild\u2013moderate AD, supporting the interpretation that the device is used as a cognitive enhancer in this context. \ue200cite\ue202turn0search4\ue202turn0search7\ue201",
        "Reflect: The classification 'cognitive enhancer' aligns with the trial description (treatment for AD with expected cognitive benefit and assessment of sleep quality). rTMS is not a biologic or small molecule and is not primarily targeted at neuropsychiatric/behavioral symptoms (though sleep is a symptom domain); therefore the symptom\u2011management category is less fitting than cognitive enhancement. No specific drug was found or required. \ue200cite\ue202turn0search6\ue202turn0search3\ue201",
        "Web search results (selected supporting sources):",
        "- The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta\u2011analysis. \ue200cite\ue202turn0search0\ue201",
        "- Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer\u2019s Disease: A Meta\u2011Analysis (2024). \ue200cite\ue202turn0search2\ue201",
        "- Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta\u2011analysis of randomized controlled trials. \ue200cite\ue202turn0search4\ue201",
        "- Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: a systematic review and Bayesian network meta\u2011analysis. \ue200cite\ue202turn0search6\ue201",
        "- Repetitive Transcranial Magnetic Stimulation for Improving Cognitive Function in Patients With Mild Cognitive Impairment: A Systematic Review. \ue200cite\ue202turn0search3\ue201"
    ],
    "agent_type": "M) Synaptic Plasticity/Neuroprotection",
    "explanation_agent": [
        "Reason: The intervention is repetitive transcranial magnetic stimulation (rTMS), a non\u2011invasive neuromodulation technique intended to produce symptomatic cognitive improvement (and assessed for sleep effects) rather than to modify molecular AD pathology (amyloid, tau, ApoE, etc.). rTMS is reported to improve global cognition and memory in AD trials and meta-analyses. \ue200cite\ue202turn0search1\ue202turn0search3\ue201",
        "Act: Extracted details \u2014 Intervention: rTMS (no drug listed); Procedure: localization followed by repeated stimulation; Therapeutic aim: cognitive enhancement / symptomatic improvement and sleep quality. Proposed mechanisms in the literature include modulation of cortical excitability, enhancement of synaptic plasticity and neurotrophic signaling, and modulation of neurotransmitter systems \u2014 mechanisms that align with the CADRO category for synaptic plasticity/neuroprotection. \ue200cite\ue202turn0search5\ue202turn0search6\ue201",
        "Reflect: rTMS is a device-based neuromodulatory treatment focused on improving cognition (symptomatic, plasticity\u2011based) rather than targeting a specific molecular pathology; therefore the most specific CADRO match is M) Synaptic Plasticity/Neuroprotection. Alternative categories (e.g., D) Neurotransmitter Receptors) are less appropriate because the intervention does not directly target a defined receptor pharmacologically, and T) Other is not appropriate because this is a therapeutic intervention. Evidence summaries and RCT meta-analyses support rTMS cognitive effects; there is also literature on sleep/circadian effects but the primary mechanistic rationale remains plasticity/neuroprotection. \ue200cite\ue202turn0search1\ue202turn0search7\ue201",
        "Web search results (selected):",
        "- Meta-analysis showing rTMS improves global cognition/memory in AD (Sha Li et al., 2024). \ue200cite\ue202turn0search1\ue201",
        "- PubMed summary/meta-analysis of rTMS in AD (systematic review and meta-analysis). \ue200cite\ue202turn0search3\ue201",
        "- Earlier meta-analyses and systematic reviews reporting cognitive benefit of rTMS in AD. \ue200cite\ue202turn0search4\ue202turn0search6\ue201",
        "- Review describing mechanisms (synaptic plasticity, neurotrophic factors, modulation of neurotransmitter systems) that underlie rTMS effects in AD. \ue200cite\ue202turn0search5\ue201",
        "- Trial evidence linking rTMS to modulation of cognitive effects related to sleep deprivation / HPA axis and BDNF (relevant to sleep quality outcomes). \ue200cite\ue202turn0search7\ue201"
    ]
}